4.6 Letter

Glycoprotein acetyls (GlycA) at 12 months are associated with high-sensitivity C-reactive protein and early life inflammatory immune measures

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk

Margery A. Connelly et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Article Public, Environmental & Occupational Health

Cohort Profile: The Barwon Infant Study

Peter Vuillermin et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)

Article Biochemistry & Molecular Biology

The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection

Scott C. Ritchie et al.

CELL SYSTEMS (2015)

Article Cardiac & Cardiovascular Systems

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events

Akintunde O. Akinkuolie et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Article Nutrition & Dietetics

Developmental origins of noncommunicable disease: population and public health implications

Mark Hanson et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)